Literature DB >> 9861571

Clearance of hepatitis G virus infection in thalassaemic children.

Y Poovorawan, A Theamboonlers, A Surastian, P Seksarn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9861571     DOI： 10.1007/bf02770848

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  5 in total

1.  Detection of antibodies to a putative hepatitis G virus envelope protein.

Authors:  M Tacke; K Kiyosawa; K Stark; V Schlueter; B Ofenloch-Haehnle; G Hess; A M Engel
Journal:  Lancet       Date:  1997-02-01       Impact factor: 79.321

2.  Infection with hepatitis G virus among recipients of plasma products.

Authors:  L M Jarvis; F Davidson; J P Hanley; P L Yap; C A Ludlam; P Simmonds
Journal:  Lancet       Date:  1996-11-16       Impact factor: 79.321

3.  Prevalence of infection with hepatitis G virus among various groups in Thailand.

Authors:  Y Poovorawan; A Theamboonlers; V Chongsrisawat; P Jantaradsamee
Journal:  Ann Trop Med Parasitol       Date:  1998-01

4.  Isolation of novel virus-like sequences associated with human hepatitis.

Authors:  J N Simons; T P Leary; G J Dawson; T J Pilot-Matias; A S Muerhoff; G G Schlauder; S M Desai; I K Mushahwar
Journal:  Nat Med       Date:  1995-06       Impact factor: 53.440

5.  Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent.

Authors:  J Linnen; J Wages; Z Y Zhang-Keck; K E Fry; K Z Krawczynski; H Alter; E Koonin; M Gallagher; M Alter; S Hadziyannis; P Karayiannis; K Fung; Y Nakatsuji; J W Shih; L Young; M Piatak; C Hoover; J Fernandez; S Chen; J C Zou; T Morris; K C Hyams; S Ismay; J D Lifson; G Hess; S K Foung; H Thomas; D Bradley; H Margolis; J P Kim
Journal:  Science       Date:  1996-01-26       Impact factor: 47.728
  5 in total
  1 in total

1.  Hepatitis TT virus infection in high-risk groups.

Authors:  Y Poovorawan; A Theamboonlers; P Jantaradsamee; N Kaew-in; P Hirsch; P Tangkitvanich
Journal:  Infection       Date:  1998 Nov-Dec       Impact factor: 3.553
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.